Switching From Efavirenz to Atazanavir/ Ritonavir in HIV-infected Subjects With Good Virologic Suppression

NCT01194856 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

1

Enrollment

OTHER

Sponsor class

Stopped Closed due to low enrollment

Conditions

HIV Infection
Mitochondrial Dysfunction

Interventions

DRUG: Atazanavir/ritonavir
DRUG: Efavirenz

Sponsor

The Cleveland Clinic

Collaborators

[object Object]
[object Object]
[object Object]